HEPATIC FUNCTION ABNORMAL
Clinical trials for HEPATIC FUNCTION ABNORMAL explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FUNCTION ABNORMAL trials appear
Sign up with your email to follow new studies for HEPATIC FUNCTION ABNORMAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First test: how does a damaged liver handle a new drug?
Knowledge-focused CompletedThis early-stage study aimed to understand how liver problems affect how the body processes a single dose of an experimental drug called venglustat. It involved 26 adults, some with varying levels of liver impairment and others with normal liver function. The main goal was to mea…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC
-
Drug safety check: how does a damaged liver handle this medicine?
Knowledge-focused CompletedThis study aimed to understand how liver problems affect the way the body processes the drug fexinidazole. It involved 21 adults, some with mild or moderate liver impairment and others with normal liver function, who each took a single dose. Researchers measured the drug levels i…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC